Pleomorphic
group of non-spore forming anaerobic
Gram-negative (some weakly or variable staining) bacilli (see WebLinked
image)
Genus
Bacteroides formerly included the genera Porphyromonas
and Prevotella
Bacteroides fragilis group
Non-fragilis Bacteroides (many species)
Abscess
formation in normally sterile sites
Bacteremia
Intraabdominal
infections: more than 80% caused by B. fragilis
Gynecological
infections: polymicrobial anaerobic infections with B. fragilis frequently
causing abscesses
Skin
and soft tissue infections: most commonly associated with B. fragilis;
Gram-negative anaerobes gain access to these sites via bites or trauma
Respiratory
tract: polymicrobial infections including non-fragilis Bacteroides
Normal
flora of upper respiratory and gastrointestinal tract which are colonized in
large numbers
Endogenous
spread to normally sterile sites
Although
Bacteroides fragilis is relatively minor member of the normal flora of
the gastrointestinal tract, more than 80% of all intraabdominal infections are
associated with B. fragilis
Surgical and trauma patients
Patients with spontaneous peritonitis
Virulence
factors can be organized into three broad categories:
Fimbriae and agglutinins function as adhesins
Polysaccharide
capsule
Lipopolysaccharide
Oxygen tolerance
Wide array of enzymes:
Specimen
collection to avoid contamination with normal flora
Oxygen-free
transport medium system
Avoid
drying
Bacteroides spp. grow rapidly (within two days) but most other anaerobes
are slow growers on selective media
B. fragilis are resistant to kanamycin, vancomycin and colistin
B. fragilis growth is stimulated in the presence of 20% bile
Surgical
drainage of abscess(es) and removal of necrotic tissue(s)
Long-term course of antibiotics
Prophylatic use of antibiotics
Virulence of Polysaccharide Capsule of Bacteroides fragilis
|
||||
DESCRIPTION
|
BIOLOGICAL
MATERIAL |
INFECTION
METHOD |
DISEASE
OBSERVED |
ORGANISMS
ISOLATED |
MIXED
|
Fecal Pellet
|
Intraperitoneal
Injection (Simulates intraabdominal infection) |
Peritonitis
or |
E. coli,
Enterococcus, Bacteremia |
Intraabdominal
Abscess |
B. fragilis
|
|||
MIXED
|
Nonencapsulated
B. fragilis + Enterococcus |
IP Injection
|
Intraabdominal
Abscess |
B. fragilis
+ Enterococcus |
MIXED
|
Encapsulated
B. fragilis + Enterococcus |
IP Injection
|
Intraabdominal
Abscess |
B. fragilis
|
LIVE
|
Encapsulated
B. fragilis |
IP Injection
|
Intraabdominal
Abscess |
B. fragilis
|
LIVE
CONTROL |
Encapsulated
Streptococcus pneumoniae |
IP Injection
|
No Disease
|
---
|
LIVE
CONTROL |
Enterococcus
|
IP Injection
|
No Disease
|
---
|
LIVE
|
Nonencapsulated
B. fragilis |
IP Injection
|
No Disease
|
---
|
DEAD
|
Heat-killed
Encapsulated B. fragilis |
IP Injection
|
Intraabdominal
Abscess |
Sterile
|
SUBUNIT
|
Purified
B. fragilis Capsule |
IP Injection
|
Intraabdominal
Abscess |
Sterile
|
SUBUNIT
CONTROL |
Purified
E. coli Capsule |
IP Injection
|
No Disease
|
---
|
Lecture Syllabus | General Course Information | Grade Determination |
Laboratory Syllabus | Interesting WebSite Links | Lab Safety |